product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
LYPLA2 Antibody (02) [DyLight 350]
catalog :
NBP3-05819UV
quantity :
0.1 ml
price :
369 USD
clonality :
monoclonal
host :
mouse
conjugate :
DyLight 350
clone name :
02
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP3-05819UV
SKU :
NBP3-05819UV
product name :
LYPLA2 Antibody (02) [DyLight 350]
sizes available :
0.1 ml
description :
The LYPLA2 Antibody (02) [DyLight 350] from NBP3-05819UV is a 6.7e-05 antibody to . This antibody reacts with human.
target :
LYPLA2
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
02
conjugate :
DyLight 350
all_available conjugate :
DyLight 488;CoraFluor 1;Janelia Fluor 646;Alexa Fluor 532;Alexa Fluor 700;DyLight 594;Janelia Fluor 525;Alexa Fluor 750;FITC;DyLight 350
dilution :
ELISA
host :
Mouse
immunogen :
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human LYPLA2 (Uniprot#: O95372; Met 1-Val 231).
isotype :
IgG2b
purity :
Protein A purified
species :
Human
specificity :
No cross-reactivity in ELISA with: E.coli cell lysate
gene symbol :
LYPLA2
applications :
ELISA
USD :
369 USD
alt names :
acyl-protein thioesterase 2, APT2, DJ886K2.4, EC 3.1.2, EC 3.1.2.-, LPL-II, lysophospholipase IIAPT-2LysoPLA II
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
